Clinical characteristics
|
Age (years)
|
32 (19 to 67)
|
32 (19 to 59)
|
34 (22 to 53)
|
0.449 c
|
Male (n, %)
|
37 (75.5%)
|
110 (90.9%)
|
71 (97.3%)
|
< 0.0001a
|
BMI (kg/m2)
|
21.83 (11.87 to 36.73)
|
22.76(15.06 to 36.98)
|
23.39 (15.22 to 37.11)
|
0.078 c
|
Disease duration (years)
|
10 (0.5 to 40.3)
|
10.5 (1.0 to 30.0)
|
14 (0.5 to 34)
|
0.114 c
|
Bilateral THA (n, %)
|
8 (16.3%)
|
84 (69.4%)
|
71 (97.3%)
|
< 0.0001a
|
Hip ROM = 0° (n, %)
|
10 (20.4%)
|
60 (49.6%)
|
51 (69.9%)
|
< 0.0001a
|
BASRI-hip score of 4 (n, %)
|
16 (32.7%)
|
68 (56.2%)
|
55 (75.3%)
|
< 0.0001a
|
Preoperative laboratory values
|
Elevated level of ESR (n, %)
|
23(46.9%)
|
75(62.0%)
|
34(46.6%)
|
0.058a
|
Elevated level of CRP (n, %)
|
31 (63.3%)
|
89 (73.6%)
|
45 (61.6%)
|
0.168a
|
TT (s)
|
15.7 ± 0.8
|
16.2 ± 1.0
|
16.2 ± 1.0
|
0.013b
|
APTT (s)
|
40.6 ± 4.8
|
41.4 ± 4.7
|
38.7 ± 4.9
|
0.001b
|
PT (s)
|
13.6 ± 0.8
|
13.5 ± 0.8
|
13.4 ± 0.9
|
0.206b
|
PT (%)
|
93.2 ± 11.3
|
93.9 ± 11.9
|
96.1 ± 12.7
|
0.346b
|
INR
|
1.06 ± 0.08
|
1.05 ± 0.08
|
1.03 ± 0.08
|
0.219b
|
Fibrinogen level (g/L)
|
4.04 (2.42 to 7.41)
|
4.45 (1.90 to 13.10)
|
4.06 (1.76 to 6.16)
|
0.014c
|
Platelet level (× 109/L)
|
270 ± 67
|
289 ± 77
|
249 ± 58
|
0.001b
|
Hb level (g/L)
|
127 ± 15
|
131 ± 16
|
140 ± 16
|
< 0.0001b
|
Hct (L/L)
|
0.386 ± 0.041
|
0.401 ± 0.042
|
0.423 ± 0.041
|
< 0.0001b
|
Perioperative data
|
Iliopsoas and adductor release (n, %)
|
2 (4.1%)
|
23 (19.0%)
|
16 (21.9%)
|
0.024a
|
Administration of TXA (n, %)
|
40 (81.6%)
|
77 (63.6%)
|
42 (57.5%)
|
< 0.0001a
|
Chemoprophylaxis of thrombosis (n, %)
|
30(61.2%)
|
97(80.2%)
|
56(76.7%)
|
0.033a
|
Operating time (min)
|
100 (55 to 250)
|
180 (60 to 335)
|
210 (70 to 455)
|
< 0.0001c
|
Autologous transfusion (n, %)
|
3 (6.1%)
|
30 (24.8%)
|
33 (45.2%)
|
< 0.0001a
|
Allogenic transfusion (n, %)
|
37 (75.5%)
|
119 (98.3%)
|
73 (100%)
|
N/A
|
ASA class
| | | |
0.672a
|
1
|
5
|
6
|
4
| |
2
|
40
|
105
|
65
| |
3
|
4
|
10
|
4
| |